Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2008-05-13
2008-05-13
Wehbe, Anne Marie (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S021000, C800S008000, C800S012000, C800S013000, C800S014000
Reexamination Certificate
active
07371920
ABSTRACT:
The present invention provides a transgenic animal model of Alzheimer's Disease designated TgCRND8 as well as a method for making such model, which allows for the characterization of the etiology of the disease as well as for provide a system for the development and testing of potential treatments.
REFERENCES:
patent: 5455169 (1995-10-01), Mullan
patent: 5612486 (1997-03-01), McConlogue et al.
patent: 5672805 (1997-09-01), Neve
patent: 5850003 (1998-12-01), McLonlogue et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5894078 (1999-04-01), Nalbantoglu et al.
patent: 5898094 (1999-04-01), Duff et al.
patent: 6037521 (2000-03-01), Sato et al.
patent: 6117978 (2000-09-01), St. George-Hyslop et al.
patent: 6175057 (2001-01-01), Mucke et al.
patent: 6262335 (2001-07-01), Hsiao et al.
patent: 6509515 (2003-01-01), Hsiao et al.
patent: 2001/0016951 (2001-08-01), Sommer et al.
patent: WO 96/34099 (1996-10-01), None
patent: WO 96/40895 (1996-12-01), None
patent: WO 99/09150 (1999-02-01), None
Lannfelt et al. Behav Brain Res (1993), 57:207-213.
Felsenstein et al. Alz Parkinson's Diseases (1995) Hannin et al (Eds.), Plenum Pres, New York, NY, pp. 401-409.
Higgins et al.Annals NY Acad Sci (1993) 695:224-227.
Hammer et al. 1986, J. of Anim. Sci., 63: 269-278.
Andra et al., 1996, Neurobiology of Aging, 17: 183-190.
Carlson et al., 1997, Human Molecular Genetics, 6: 1951-1959.
Hisao et al., 1995, Neuron, 15: 1203-1218.
Chishti, et al., 2001, Journal of Biological Chemistry, 276: 21562-21570.
Hsia et al., 1999, PNAS, USA, 96: 3228-3233.
Jin et al., 2004, PNAS, USA, 101, 13363-13367.
Selkoe, 2002, Science, 298, 789-791.
Blast [online], 2006 [retrieved on Dec. 7, 2006]. Retrieved from the Internet:< URL: <http://www.ncbi.nlm.nih.gov/BLAST/Blast/cgi>, 2 pages.
Van Leuven, F. (2000) “Single and multiple transgenic mice as models for Alzheimer's Disease”, Prog. Neurobiol., 61: 305-312.
Sturchler-Pierrat, C. et al., (1997) “Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology”, Proc Natl Acad Sci USA 94(24), 13287-92.
Hsia Ay et all, (1999) “Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models”, Proc Natl Acad Sci USA. 96,3228-33.
McGowan et al., (1999) “Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes”, Neurobiol. of Disease, 6:231-244.
Holcomb L., Gordon MN., McGowan E., et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutantamyloid precursor proteinandpresenilin 1transgenes, Nature Med., 4:97-100.
Kang, J. et al., (1987) “The precursor of Alzheimer disease amyloid A4 protein resembles a cell-surface receptor”, Nature, 325:733-736.
Mullan, M.J., et al., (1992) “A pathogenic mutation for probable Alzheimer's Disease in the APP gene at the N-terminus of B-amyloid”, Nature Genetics, 1:345-347.
Murrell, J., et al., (1991) “A mutation in the amyloid precursor protein associated with hereditary Alzheimer's Disease”, Science, 254:97-99.
Citron M., et al., (1992) “Mutation of the B-amyloid precursor protein in familial Alzheimer's Disease increases B-protein production”, Nature, 360:672-674.
Citron, M., et al., (1994) “Excessive production of amyloid B-Protein by peripheral cells of symptomatic and presypmtomatic patients carrying the Swedish Familial Alzheimer's Disease mutation”, Proc. Natl. Acad. Sci. USA, 91:11993-11997.
Haass, C., et al., (1995) “The Swedish mutation causes early onset Alzheimer's disease by B-secretase cleavage within the secretory pathway”, Nature Med., 1:1291-1296.
Haass, C., et al., (1991) “Processing of Beta-Amyloid precursor protein in microglia and astrocytes favours an internal localization over constitutive secretion”, J. Neurosci., 11:3783-3793.
Haass; C., et al., (1994) Mutations associated with locus for familial Alzheimer's Disease result in alternative processing of amyloid B-protein precursor, J. Biol. Chem., 269:17741-17748.
Shoji, M., et al., (1992) “Production of the Alzheimer amyloid B protein by normal proteolytic processing”, Science, 258: 126-129.
Scott, M.R., et al., (1992) “Chimeric prion protein expression in cultured cells and transgenic mice”, Protein Sci., 1:986-997.
Nee, L., et al., (1983) “A family with histologically confirmed Alzheimer Disease”, Arc. Neurol., 40:203-208.
Foncin, J.-F., et al., (1985) “Alzheimer's Presenile dementia transmitted in an extended kindred”, Rev. Neurol. (Paris), 141:194-202.
Frommelt., P., et al., (1991) “Familial Alzheimer Disease: A Large Multigenerational German Kindred”, Alzheimer Dis. Assoc. Disorders, 5:406-412.
Lippa, C.F., et al., (1996) “Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway”, Neurology, 46:406-412.
Lippa, C.F., et al., (1998) “Abeta42 deposition precedes other changes in PS1 Alzheimer's Disease”, Lancet, 352:1117-1118.
Games, D., et al., (1995) “Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein”, Nature, 373:523-527.
Hsiao, K., et al., (1996) “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice”, Science, 274:99-102.
Moechars, D.,et al., (1999) “Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein”, J. Biol. Chem., 274:6483-6492.
Citron, M., et al., (1998) “Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein”, Neurobiol. Dis., 5:107-116.
Borchelt, D.R., et al., (1998) “Accelerated amyloid deposition in brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins”, Neuron, 19:939-945.
Palmiter, R.D., and Brinster, R.L., (1986) “Germ-line transformation of mice”, Annu. Rev. Genet. 20:465-499.
Lu et al., (2000) “A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor”, Nature Medicine, 6:397-404.
Schenk, D., et al., (1999) “Immunization with amyloid-beta attenuates Alzheimer-Disease-like pathology in the PDAPP mouse”, Nature, 400:173-177.
Carlson, G.A., et al., (1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice, Hum. Mol. Genet., 6:1951-1959.
Scott et al., (1989) “Transgenic mice expressing hamster prion produce species-specific scrapie infectivity and amyloid plaques”, Cell 59:847-857.
Morris, R.G.M., (1984) “Developments of a water-maze procedure for studying spatial learning in the rat”, J. Neuroscience Methods, 11:47-60.
Janus, C., D'Amelio, S., Amitay, O., Chishti, M.A., Strome, R., Fraser, P.E., Carlson, G.A., Roder, J., St. George-Hyslop, P. and Westway, D., (2000) “Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes”, Neurobiology Aging, 21:541-549.
Feinberg, A.P., and Vogelstein, B., (1983) “A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity”, Anal. Biochem., 132:6-13.
Citron, M., et al. (1997) “Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice”, Nature Medicine, 3:67-72.
Forss-Petter et al., (1990) “Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control”, Neuron 5:187-97.
Sasahara et al., (1991) “PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model”, Cell 64:217-227.
Prusiner et al., (1990) “Transgenic studies implicate interactions between homologous PrP isoforms in scarpie prion replication”, Cell
Fraser Paul E.
St. George-Hyslop Peter H.
Westaway David
Doss Raymond M.
Haley Jr. James F.
Hama Joanne
Ropes & Gray LLP
The Governing Council of the University of Toronto
LandOfFree
Transgenic mouse model of neurodegenerative disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic mouse model of neurodegenerative disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic mouse model of neurodegenerative disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2756727